M&A Dealmakers Announced 869 Transactions in 90 Days—Strategic Buyers Are Back in Force

Eight hundred sixty-nine M&A deals announced in a single quarter is not normal. An average deal size of $3 billion is not normal. And a week where corporate buyers announced 180 transactions, yet another where they hit 184, approaches not just activity but frenzy. Something has shifted in the M&A universe, and it's no longer a whisper.

The past 90 days have delivered the clearest proof yet that strategic corporate acquisitions have redefined dealmaking at scale. While private equity continues to dominate headlines—mega-funds closing flagship vehicles at record speed, secondary deals hitting valuations previously thought untouchable—the strategic buyer universe has quietly assembled a 13-week stretch that reshapes how we think about capital deployment, deal pricing, and the competitive positioning of large corporations in an age of technological disruption and macro volatility.

Volume as a Signal of Structural Shift

869 reported M&A transactions across 90 days. That's 67 deals per week. That's 10 per day. When you zoom into the actual market data, the concentration becomes even more visible: the week of March 30 saw 180 announced transactions. Three weeks prior, 184. The week of March 16 hit 157. These are not random fluctuations; they represent the quantifiable expression of a market operating at a genuinely new equilibrium.

For context: in comparable periods from prior years, a 40-deal-per-week average would be considered robust. Today, we're observing averages of 67, with peak weeks nearly tripling the old baseline. The magnitude matters because it signals not incremental change but structural reallocation. Somewhere, in corporate finance departments across Fortune 500 companies, strategies have shifted. Somewhere, boards have authorized capital deployment at scales not seen in the past cycle.

And the scale of individual transactions reinforces this reading. Of the deals with publicly disclosed values—itself a subset, as many mid-market transactions remain private—the average exceeded $3 billion. That's not the typical median deal from buyout shops or growth equity firms. That's the realm of mega-cap acquisitions, consolidation plays, and strategic repositioning where entire business units are being shuffled or removed from the public domain.

Seventy-two transactions topped the billion-dollar threshold in this period. The largest—Paramount's $24 billion financing commitment supporting its pursuit of Warner Bros. Discovery—sits at the scale of sovereign wealth allocations. Hologic's take-private auction completed at $18.3 billion. CVC's public bid for Recordati stands at $12.7 billion and has sparked competitive interest. These are not hidden, behind-the-scenes battles; they're public, prominent, capital-intensive contests for control of world-class assets.

The Mega-Deal Phenomenon and Valuation Signals

What becomes immediately apparent when you examine the composition of disclosed deal values is this: mega-deals—those north of $5 billion—capture an outsized share of total capital, while the bulk of the numerical deal count lives in smaller, often-undisclosed transactions that stay off public radars.

The distribution is instructive for dealmakers and investors alike. Of the 127 transactions with publicly disclosed values, most cluster in the $1-5 billion range. But a small handful of deals exceeding $5 billion—Paramount, Hologic, Recordati, the select few—capture the lion's share of announced capital. A single $24 billion transaction equals the combined value of dozens of mid-market buyouts.

This concentration has important implications. It suggests that strategic buyers are not shying away from the largest and most contested prizes in the market. The competitive dynamics that would have relegated mega-cap targets to exclusive private equity auctions in past cycles are now featuring corporate bidders as serious contenders. When Paramount can marshal $24 billion in committed financing to pursue a media giant, it's not a side bet—it's a clear statement that strategic players intend to compete across all deal sizes.

It also signals something about valuations. The Hologic take-private, for instance, closed at a 45% premium to the company's pre-deal trading price. The CVC bid for Recordati values the company significantly above its historical trading range. These are not distressed transactions negotiated from weakness; they're premium-priced acquisitions executed by buyers who explicitly believe public markets have mispriced these assets. Whether the thesis is growth runway, operational upside, or pure financial engineering, the premium being paid is real and material.

The AI Acquisition Gold Rush

Sector analysis reveals a pattern that probably shouldn't surprise but still carries weight: artificial intelligence and enterprise software dominated deal flow by disclosed value and deal count. Over 20 discrete acquisitions in the AI and software space, representing an estimated $63.7 billion in total disclosed value, stand as the second-largest cross-sector deployment after mega-deals in media and telecom.

These are not venture-backed startups raising Series C rounds with enterprise customers. These are mature, profitable software and AI platform companies being acquired by strategic players seeking to embed capability, accelerate product roadmaps, consolidate competitive threats, or accelerate entry into adjacent markets. A few marquee examples:

Amazon's $11.6 billion acquisition of Globalstar for satellite communications capacity is a direct geopolitical bet. The company is competing with SpaceX's Starlink and needs low-earth-orbit infrastructure to enable broadband coverage in underserved regions. Rather than invest a decade in organic satellite development, Amazon is acquiring an operational asset with licensed spectrum and customer relationships.

Credo Semiconductor's $750 million acquisition of DustPhotonics targets advanced silicon photonics for high-speed data transmission. Hex Robotics' $1.45 billion acquisition of Waygate Technologies brings non-destructive testing AI into a massive industrial inspections market. These are not vanity acquisitions or talent buys; they're strategic plays where the acquirer has identified a gap, priced the asset based on strategic value rather than financial model cashflows, and moved decisively to integrate.

The pace matters. Twenty distinct AI and software acquisitions in a single quarter tells us that strategic buyers have decided the time-to-market penalty of organic development is too high, the talent acquisition risk is too steep, and the optionality embedded in these teams and codebases is worth acquiring at premium multiples. In a competitive landscape where AI and software are reshaping every industry vertical, the acquisition engine is running at maximum RPM.

Take-Privates as a Reallocation Mechanism

Embedded within the broader M&A wave is a distinct subcategory: take-private transactions where public-company shareholders are being cashed out at premium prices, and ownership is being relocated to strategic buyers or private financial sponsors. These deals operate on a different logic than acquisitions of private assets or privately-held companies.

The Hologic case closed at $18.3 billion—a deal that requires management lock-up agreements, shareholder votes, and SEC filing scrutiny. The Recordati bid by CVC stands at $12.7 billion and is explicitly designed to take a profitable, mid-cap pharmaceutical services company off the public markets. Dozens of smaller take-private transactions fill out the quarter's ledger.

These moves signal a clear thesis: public equity markets have mispriced a cohort of mid-cap industrial, healthcare, and business services companies. If strategic buyers and private equity sponsors are willing to deploy capital at substantial premiums to trading prices, it implies public markets are either (a) too risk-averse, (b) too focused on quarterly earnings and not long-term optionality, or (c) simply unable to price in the full value of what these companies can achieve under different ownership structures.

Over a 90-day period where 72 mega-deals crossed the billion-dollar threshold, take-privates represent a significant exit mechanism. They're removing quality mid-cap assets from the public domain and reconstituting them as private vehicles, where capital can be deployed patient and unconventional strategies are possible. That reallocation, if sustained, gradually shrinks the universe of publicly-listed companies and concentrates ownership with parties willing to hold for longer durations.

What the Momentum Actually Represents

Weekly deal announcements peaked in late March at 180+ transactions. That level cannot and should not be maintained indefinitely; it suggests compressed deal calendars, accelerated closing timelines, or statistical clustering. April's moderation to 50 reported deals is expected and healthy—but it arrives against a 67-deal-per-week baseline, meaning even "cooler" weeks remain robust by historical standards.

The most-watched metric going forward is whether the market settles into a new baseline. If weekly announcements hold above 60 deals, we're looking at a structural shift—a new normal where dealmakers, boards, and investors treat this volume as the ambient environment. If volume collapses back to pre-March levels, we'd be forced to conclude the spike was seasonal or temporary. The leading indicators—board approval timelines, capital availability from strategic acquirers, and continued mega-deal announcements—suggest the former is more likely.

The Quarter Ahead: What to Watch

For the remainder of Q2 2026, three dynamics deserve close attention:

First, deal count sustainability. If the average deal count remains above 60 per week, it confirms that strategic buyers have fundamentally reset their capital allocation posture. If it drops below 40, we're witnessing a mean reversion to older patterns. The data from the past 90 days suggests the former; the pattern of activity is too consistent to be noise.

Second, the competitive position of strategic buyers in mega-deals. Will corporate acquirers continue to bid against private equity at the $10B+ scale, or will PE reclaim dominance in the largest auctions? The Paramount-Warner Bros. saga and the Recordati bid suggest strategic players are serious participants. If that pattern persists, it marks a clear departure from prior-cycle norms where mega-deals belonged to PE shops.

Third, the valuation trajectory of take-privates. Are public shareholders being compensated with premiums that justify the deal certainty risk, or are premiums compressing as buyers anticipate further downside? Take-private premiums in the 35-50% range, as we've seen in recent weeks, imply conviction from the buyer—they believe significant upside exists post-close. Those premiums will be the market's leading indicator of whether boards are properly representing shareholder interests.

The past 90 days were not an anomaly. They were a demonstration of structural change in dealmaking: strategic buyers with enormous balance sheets, clear capital discipline, and the bandwidth to compete alongside private equity for the largest targets. That shift, once visible only in sporadic mega-deals or sector-specific plays, is now the baseline rhythm of the market. Every week, dozens of transactions are underway. Most stay private. But the momentum is unmistakable, and it's reset expectations for capital deployment across the investment landscape.